New Zealand - English - Medsafe (Medicines Safety Authority)

research associates ltd - pantoprazole sodium sesquihydrate 22.57mg equivalent to pantoprazole 20 mg;  ;   - enteric coated tablet - 20 mg - active: pantoprazole sodium sesquihydrate 22.57mg equivalent to pantoprazole 20 mg     excipient: calcium stearate crospovidone hypromellose iron oxide yellow mannitol methacrylic acid copolymer opacode brown s-1-16530 polysorbate 80 povidone propylene glycol purified water sodium carbonate sodium laurilsulfate titanium dioxide triethyl citrate - symptomatic relief of heartburn, acid regurgitation and other symptoms asssociated with gastro-oesophageal reflux disease (gord)

New Zealand - English - Medsafe (Medicines Safety Authority)

research associates ltd - tacrolimus 0.5mg - capsule - 0.5 mg - active: tacrolimus 0.5mg excipient: croscarmellose sodium gelatin hypromellose iron oxide yellow lactose monohydrate magnesium stearate purified water titanium dioxide - primary immunosuppression in liver, kidney, pancreas, kidney-pancreas, lung or heart allograft recipients and rescue use in liver, kidney or other solid organ (heart, lung, pancreas or kidney-pancreas) transplantation, that has either failed conventional immunosuppressive agents, or where such agents are producing intolerable side effects.

New Zealand - English - Medsafe (Medicines Safety Authority)

research associates ltd - tacrolimus 1mg - capsule - 1 mg - active: tacrolimus 1mg excipient: croscarmellose sodium hypromellose lactose monohydrate magnesium stearate - primary immunosuppression in liver, kidney, pancreas, kidney-pancreas, lung or heart allograft recipients and rescue use in liver, kidney or other solid organ (heart, lung, pancreas or kidney-pancreas) transplantation, that has either failed conventional immunosuppressive agents, or where such agents are producing intolerable side effects.

New Zealand - English - Medsafe (Medicines Safety Authority)

research associates ltd - tacrolimus 5mg - capsule - 5 mg - active: tacrolimus 5mg excipient: croscarmellose sodium gelatin hypromellose iron oxide red lactose monohydrate magnesium stearate opacode white s-1-18086 titanium dioxide water - primary immunosuppression in liver, kidney, pancreas, kidney-pancreas, lung or heart allograft recipients and rescue use in liver, kidney or other solid organ (heart, lung, pancreas or kidney-pancreas) transplantation, that has either failed conventional immunosuppressive agents, or where such agents are producing intolerable side effects.

New Zealand - English - Medsafe (Medicines Safety Authority)

research associates ltd - tacrolimus 5 mg/ml - concentrate for infusion - 5 mg/ml - active: tacrolimus 5 mg/ml excipient: ethanol hydrogenated castor oil nitrogen - primary immunosuppression in liver, kidney, pancreas, kidney-pancreas, lung or heart allograft recipients and rescue use in liver, kidney or other solid organ (heart, lung, pancreas or kidney-pancreas) transplantation, that has either failed conventional immunosuppressive agents, or where such agents are producing intolerable side effects.

New Zealand - English - Medsafe (Medicines Safety Authority)

research associates ltd - tacrolimus 0.5mg - modified release capsule - 0.5 mg - active: tacrolimus 0.5mg excipient: ethanol ethylcellulose gelatin hypromellose iron oxide red iron oxide yellow lactose monohydrate magnesium stearate opacode red s-1-15083 sodium laurilsulfate titanium dioxide - primary immunosuppression in liver, kidney, pancreas, kidney-pancreas, lung or heart allograft recipients and rescue use in liver, kidney or other solid organ (heart, lung, pancreas or kidney-pancreas) transplantation, that has either failed conventional immunosuppressive agents, or where such agents are producing intolerable side effects.

New Zealand - English - Medsafe (Medicines Safety Authority)

research associates ltd - tacrolimus 1mg - modified release capsule - 1 mg - active: tacrolimus 1mg excipient: ethanol ethylcellulose gelatin hypromellose opacode s-1-15083 (trace, see tt70-) iron oxide red iron oxide yellow lactose monohydrate magnesium stearate sodium laurilsulfate titanium dioxide - primary immunosuppression in liver, kidney, pancreas, kidney-pancreas, lung or heart allograft recipients and rescue use in liver, kidney or other solid organ (heart, lung, pancreas or kidney-pancreas) transplantation, that has either failed conventional immunosuppressive agents, or where such agents are producing intolerable side effects.

New Zealand - English - Medsafe (Medicines Safety Authority)

research associates ltd - pioglitazone hydrochloride 16.53mg equivalent to 15 mg pioglitazone;   - tablet - 15 mg - active: pioglitazone hydrochloride 16.53mg equivalent to 15 mg pioglitazone   excipient: carmellose calcium hyprolose lactose monohydrate magnesium stearate

New Zealand - English - Medsafe (Medicines Safety Authority)

research associates ltd - pioglitazone hydrochloride 33.06mg equivalent to 30 mg pioglitazone;   - tablet - 30 mg - active: pioglitazone hydrochloride 33.06mg equivalent to 30 mg pioglitazone   excipient: carmellose calcium hyprolose lactose monohydrate magnesium stearate

New Zealand - English - Medsafe (Medicines Safety Authority)

research associates ltd - pioglitazone hydrochloride 49.59mg equivalent to 45 mg pioglitazone;   - tablet - 45 mg - active: pioglitazone hydrochloride 49.59mg equivalent to 45 mg pioglitazone   excipient: carmellose calcium hyprolose lactose monohydrate magnesium stearate